{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Risperidone%2C+divalproex", "query": { "intervention": "Risperidone, divalproex" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Risperidone%2C+divalproex&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-21T09:26:44.250Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00073164", "title": "Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Divalproex Sodium Extended-Release Tablets", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 400, "start_date": "2003-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2006-08-04", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Anaheim, California + 32 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00073164" }, { "nct_id": "NCT00308360", "title": "Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Risperidone, divalproex", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nathan Kline Institute for Psychiatric Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 46, "start_date": "1999-09", "completion_date": "2004-04", "has_results": false, "last_update_posted_date": "2006-03-29", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 1, "location_summary": "Orangeburg, New York", "locations": [ { "city": "Orangeburg", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00308360" }, { "nct_id": "NCT00794625", "title": "Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Attention Deficit Disorder With Hyperactivity" ], "interventions": [ { "name": "Valproate", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Stimulant medication", "type": "DRUG" }, { "name": "Behavioral family counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Joseph Blader", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "6 Years to 12 Years" }, "enrollment_count": 270, "start_date": "2008-11", "completion_date": "2013-04", "has_results": false, "last_update_posted_date": "2012-07-16", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 3, "location_summary": "Glen Oaks, New York • Stony Brook, New York • San Antonio, Texas", "locations": [ { "city": "Glen Oaks", "state": "New York" }, { "city": "Stony Brook", "state": "New York" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00794625" }, { "nct_id": "NCT00048802", "title": "Treatment and Outcome of Early Onset Bipolar Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Lithium", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Divalproex", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Ziprasidone", "type": "DRUG" }, { "name": "Aripriprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "10 Years to 18 Years" }, "enrollment_count": 40, "start_date": "2002-08", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2014-01-22", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 1, "location_summary": "Glen Oaks, New York", "locations": [ { "city": "Glen Oaks", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00048802" }, { "nct_id": "NCT00221403", "title": "Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Risperidone oral solution", "type": "DRUG" }, { "name": "Valproate Oral Solution", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "7 Years", "sex": "ALL", "summary": "3 Years to 7 Years" }, "enrollment_count": 46, "start_date": "2004-09", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2020-10-20", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 2, "location_summary": "Cincinnati, Ohio • Milwaukee, Wisconsin", "locations": [ { "city": "Cincinnati", "state": "Ohio" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00221403" }, { "nct_id": "NCT00208819", "title": "A Comparison of Two Standard Therapies in the Management of Dementia With Agitation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Senile Dementia, Alzheimer Type", "Dementia, Alzheimer Type", "Alzheimer Disease", "Dementia" ], "interventions": [ { "name": "risperidone", "type": "DRUG" }, { "name": "quetiapine", "type": "DRUG" }, { "name": "olanzapine", "type": "DRUG" }, { "name": "divalproex", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 50, "start_date": "2003-09", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2013-11-13", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00208819" }, { "nct_id": "NCT02893371", "title": "Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Lithium Carbonate", "type": "DRUG" }, { "name": "Lamotrigine", "type": "DRUG" }, { "name": "Valproic Acid", "type": "DRUG" }, { "name": "Oxcarbazepine", "type": "DRUG" }, { "name": "Carbamazepine", "type": "DRUG" }, { "name": "Ziprasidone", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Fluoxetine / Olanzapine", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" }, { "name": "Perphenazine", "type": "DRUG" }, { "name": "Clozapine", "type": "DRUG" }, { "name": "Asenapine", "type": "DRUG" }, { "name": "Lurasidone", "type": "DRUG" }, { "name": "Paliperidone", "type": "DRUG" }, { "name": "Mirtazapine", "type": "DRUG" }, { "name": "Bupropion", "type": "DRUG" }, { "name": "Desvenlafaxine", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" }, { "name": "Venlafaxine", "type": "DRUG" }, { "name": "Citalopram", "type": "DRUG" }, { "name": "Escitalopram", "type": "DRUG" }, { "name": "Fluoxetine", "type": "DRUG" }, { "name": "Fluvoxamine", "type": "DRUG" }, { "name": "Paroxetine", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" }, { "name": "Vilazodone", "type": "DRUG" }, { "name": "Doxepin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1037352, "start_date": "2016-09", "completion_date": "2019-06-30", "has_results": false, "last_update_posted_date": "2024-03-12", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT02893371" }, { "nct_id": "NCT00177567", "title": "Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "lithium carbonate", "type": "DRUG" }, { "name": "Depakote-ER", "type": "DRUG" }, { "name": "risperidone", "type": "DRUG" }, { "name": "olanzapine", "type": "DRUG" }, { "name": "paroxetine", "type": "DRUG" }, { "name": "bupropion", "type": "DRUG" }, { "name": "lamotrigine", "type": "DRUG" }, { "name": "venlafaxine", "type": "DRUG" }, { "name": "tranylcypromine", "type": "DRUG" }, { "name": "mirtazapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 60, "start_date": "2001-07", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2005-09-15", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 2, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00177567" }, { "nct_id": "NCT00203528", "title": "Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Substance Abuse", "Bipolar Depression" ], "interventions": [ { "name": "divalproex sodium ER", "type": "DRUG" }, { "name": "risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tuscaloosa Research & Education Advancement Corporation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "19 Years to 65 Years" }, "enrollment_count": 30, "start_date": "2004-01", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2007-03-19", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 1, "location_summary": "Tuscaloosa, Alabama", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00203528" }, { "nct_id": "NCT00057681", "title": "Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Lithium carbonate", "type": "DRUG" }, { "name": "Valproate", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "6 Years to 15 Years" }, "enrollment_count": 379, "start_date": "2003-02", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2013-04-04", "last_synced_at": "2026-09-21T09:26:44.250Z", "location_count": 5, "location_summary": "Washington D.C., District of Columbia • Baltimore, Maryland • St Louis, Missouri + 2 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00057681" } ] }